Active Ingredient History
Diltiazem is a nondihydropyridines calcium channel blocker used in the treatment of hypertension, angina pectoris, and some types of arrhythmia. Diltiazem produces its antihypertensive effect primarily by relaxation of vascular smooth muscle and the resultant decrease in peripheral vascular resistance. NCATS
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
Combination drugs
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Angina, Stable (Phase 4)
Arrhythmias, Cardiac (Phase 4)
Atherosclerosis (Phase 3)
Atrial Fibrillation (Phase 4)
Atrial Flutter (Phase 4)
Cardiomyopathy, Hypertrophic (Phase 2/Phase 3)
Cardiotoxicity (Phase 1)
Cardiovascular Diseases (Phase 3)
Colonic Polyps (Early Phase 1)
Colorectal Neoplasms (Early Phase 1)
Constipation (Phase 1)
Coronary Artery Bypass (Phase 4)
Coronary Disease (Phase 3)
Coronary Vasospasm (Phase 4)
COVID-19 (Phase 3)
Craniotomy (Phase 1/Phase 2)
Dermatology (Phase 1)
Diabetes Mellitus (Phase 3)
Diabetes Mellitus, Type 2 (Phase 3)
Diabetic Nephropathies (Phase 3)
Drug Interactions (Phase 1)
Drugs, Investigational (Early Phase 1)
Eating (Phase 1)
Endoscopy (Early Phase 1)
Fissure in Ano (Phase 4)
Healthy Volunteers (Phase 4)
Heart Diseases (Phase 3)
Hemorrhage (Phase 2/Phase 3)
Hemorrhoids (Phase 2/Phase 3)
Hepatitis C (Phase 1)
HIV Infections (Phase 1)
Hypercholesterolemia (Phase 3)
Hypertension (Phase 3)
Hypertrophy, Left Ventricular (Phase 4)
Hypotension (Early Phase 1)
Influenza A virus (Phase 2)
Ischemic Stroke (Phase 1)
Leukemia, B-Cell (Phase 1)
Metabolic Syndrome (Phase 1/Phase 2)
Microvascular Angina (Phase 3)
MINOCA (Phase 4)
Muscle Spasticity (Phase 4)
Myocardial Bridging (Phase 2)
Myocardial Infarction (Phase 4)
Myocardial Ischemia (Phase 3)
Pain (Phase 4)
Percutaneous Coronary Intervention (Phase 4)
Pharmacokinetics (Phase 1)
Pharmacologic Actions (Phase 1)
Pilot Projects (Phase 4)
Polycystic Kidney Diseases (Phase 3)
Postoperative Complications (Phase 2)
Rectal Diseases (Phase 2/Phase 3)
Reperfusion Injury (Phase 3)
Scleroderma, Systemic (Phase 2)
Substance-Related Disorders (Phase 1)
Thrombosis (Phase 1)
Vascular Grafting (Phase 4)
Verapamil (Early Phase 1)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
